USD 7.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - USD | 100.0% |
2022 | -31.28 Thousand USD | 0.13% |
2021 | -31.32 Thousand USD | 0.3% |
2020 | -31.42 Thousand USD | -0.4% |
2019 | -31.29 Thousand USD | 75.32% |
2018 | -126.84 Thousand USD | 29.13% |
2017 | -178.97 Thousand USD | 0.0% |
2009 | 544.51 Thousand USD | 486.63% |
2008 | -140.83 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q4 | - USD | 0.0% |
2023 Q1 | - USD | 100.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 FY | -31.28 Thousand USD | 0.13% |
2022 Q2 | -7823.00 USD | -0.01% |
2022 Q3 | -7824.00 USD | -0.01% |
2022 Q4 | -7821.00 USD | 0.04% |
2022 Q1 | -7822.00 USD | 0.51% |
2021 Q2 | -7823.00 USD | -0.01% |
2021 FY | -31.32 Thousand USD | 0.3% |
2021 Q4 | -7862.00 USD | -0.5% |
2021 Q3 | -7823.00 USD | 0.0% |
2021 Q1 | -7822.00 USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | -31.42 Thousand USD | -0.4% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 FY | -31.29 Thousand USD | 75.32% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | -126.84 Thousand USD | 29.13% |
2017 FY | -178.97 Thousand USD | 0.0% |
2010 Q1 | -194.08 Thousand USD | -35744.07% |
2010 Q2 | -233.6 Thousand USD | -20.36% |
2009 FY | 544.51 Thousand USD | 486.63% |
2009 Q4 | 544.52 USD | 0.0% |
2009 Q2 | 21.29 Thousand USD | -85.01% |
2009 Q1 | 142.06 Thousand USD | 0.0% |
2008 FY | -140.83 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
America Great Health | 168.58 Thousand USD | 100.0% |
Gene Biotherapeutics, Inc. | - USD | NaN% |
Evolutionary Genomics, Inc. | -1.02 Million USD | 100.0% |
Innovation1 Biotech Inc. | -52.69 Thousand USD | 100.0% |
Point of Care Nano-Technology, Inc. | -4601.00 USD | 100.0% |